diethyl[2-(piperidin-4-yloxy)ethyl]amine
Names and Identifiers of 1000819-35-1
CAS Number |
1000819-35-1 |
|---|---|
IUPAC Name |
N,N-diethyl-2-piperidin-4-yloxy-ethanamine |
Canonical SMILES |
CCN(CC)CCOC1CCNCC1 |
Physical and chemical properties of 1000819-35-1
Exact Mass |
200.18900 |
|---|---|
LogP |
1.42560 |
Molecular Formula |
C11H24N2O |
Molecular Weight |
200.32100 |
PSA |
24.50000 |
Safety Information of 1000819-35-1
Applications of 1000819-35-1
Diethyl[2-(piperidin-4-yloxy)ethyl]amine has several applications across various fields:
- Chemistry: It serves as an intermediate in the synthesis of complex organic molecules and pharmaceuticals.
- Biology: The compound is explored for its potential as a ligand in receptor binding studies and as a tool in biochemical assays.
- Medicine: It is being investigated for therapeutic properties that may lead to the development of new drugs targeting specific biological pathways.
- Industry: Utilized in producing specialty chemicals and as a reagent in various industrial processes.
Interaction Studies of 1000819-35-1
Research into the interaction of Diethyl[2-(piperidin-4-yloxy)ethyl]amine with specific receptors and enzymes reveals its potential to modulate their activity. Studies suggest that it can bind to molecular targets, influencing their function and leading to various biological effects. The exact mechanisms depend on the specific biological system being studied, highlighting the compound's versatility in biochemical applications.
Biological Activity of 1000819-35-1
The biological activity of Diethyl[2-(piperidin-4-yloxy)ethyl]amine is notable for its potential interactions with various cellular targets. It has been observed to influence cell signaling pathways, gene expression, and cellular metabolism. For instance, it may modulate the MAPK/ERK signaling pathway, impacting gene expression and cellular responses. Additionally, it has been investigated for its role as a ligand in receptor binding studies and its potential therapeutic properties in drug development targeting specific biological pathways.
